The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial
- 1 December 1992
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 66 (6) , 1171-1176
- https://doi.org/10.1038/bjc.1992.430
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Radiation-induced lung injury.1990
- A Feasibility Study of Intensive CAF as Outpatient Adjuvant Therapy for Stage II Breast Cancer in a Cooperative Group: CALGB 8443Cancer Investigation, 1990
- Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study.1988
- Adjuvant trial for stage II receptor-positive breast cancer: CMF vs. CMF+ tamoxifen in a single centreBreast Cancer Research and Treatment, 1988
- Pulmonary toxicity of a combination of low-dose doxorubicin and irradiation for inoperable lung cancerRadiotherapy and Oncology, 1987
- ADJUVANT HORMONAL CHEMOTHERAPY IN EARLY BREAST CANCER: EARLY RESULTS FROM A CONTROLLED TRIALThe Lancet, 1984
- Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancerCancer, 1984
- Treatment of Primary Breast Cancer with Chemotherapy and TamoxifenNew England Journal of Medicine, 1981
- The effect of post-operative radiotherapy in breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 1977
- Cyclophosphamide therapy and interstitial pulmonary fibrosisCancer, 1976